← All companies

Immatics

Healthcare & Life Sci

Company overview

Immatics is a biotechnology company developing cancer immunotherapies that target the PRAME protein on tumor cells, which is expressed in more than 50 cancers. Anzu-cel, also called anzutresgene autoleucel or IMA203, is a T-cell therapy. IMA402 is a bispecific therapeutic.

Immatics is headquartered in Tubingen, Germany, with additional offices in Munich and Stafford, Texas. It is a public company.

Industry
Healthcare & Life Sci
Headquarters
2 offices, United States

Filters

Create your account

Create an account to save jobs and track applications.